Why experts say there is no basis to claims in Germany about efficacy of AstraZeneca vaccine

Analysis: Drug company and scientific partners at Oxford University have strongly pushed back against German press report

A row has broken out after German newspapers suggested the Oxford/AstraZeneca vaccine might have a lower efficacy among the over-65s. Below we take a look at the claims, and whether we should be concerned.

Continue reading...

EU means business over Covid vaccine exports, says Von der Leyen

Commission president says firms must deliver on orders after AstraZeneca warns of shortfall

The EU “means business”, Ursula von der Leyen has said, as the bloc doubled down on plans for tighter monitoring of vaccine exports to countries outside of the union, such as the UK.

Speaking at the World Economic Forum, the president of the European commission said the EU had invested billions and “companies must now deliver” to the 27 member states.

Continue reading...

Pharmaceutical giants not ready for next pandemic, report warns

Ten of the world’s most infectious diseases identified by the WHO not being catered for by drug firms

The world’s biggest pharmaceutical firms are little prepared for the next pandemic despite a mounting response to the Covid-19 outbreak, an independent report has warned.

Jayasree K Iyer, executive director of the Netherlands-based Access to Medicine Foundation, a not-for-profit organisation funded by the UK and Dutch governments and others, highlighted an outbreak of the Nipah virus in China, with a fatality rate of up to 75%, as potentially the next big pandemic risk.

Continue reading...

Covid linked to risk of mental illness and brain disorder, study suggests

One in eight people who get coronavirus also have first psychiatric or neurological illness within six months, research finds

One in eight people who have had Covid-19 are diagnosed with their first psychiatric or neurological illness within six months of testing positive for the virus, a new analysis suggests, adding heft to an emerging body of evidence that stresses the toll of the virus on mental health and brain disorders cannot be ignored.

The analysis – which is still to be peer-reviewed – also found that those figures rose to one in three when patients with a previous history of psychiatric or neurological illnesses were included.

Continue reading...

I’ve had my first vaccine jab. It gives me hope of liberation… but not yet

Exactly a year after his first story about coronavirus, our science editor received the Pfizer injection last week. Here he reflects on a remarkable scientific achievement

I marked a grim anniversary in an unexpected manner last week. On 18 January last year, I wrote my first story about a mysterious disease that had struck Wuhan, in China, and which was now spreading around the world. More than two million individuals have since died of Covid-19, almost 100,000 of them in the UK.

Remarkably, 12 months to the day that the Observer published my story, I was given my first dose of Covid-19 vaccine, allowing me to follow nearly six million other newly immunised UK residents who are set to gain protection against a disease that has brought the planet to a standstill. It was a rare, comforting experience after a year of unremitting sadness and gloom.

Continue reading...

Coronavirus live news: Spain’s defence chief quits over alleged vaccination queue-jumping; UK records 1,348 deaths; Israel begins vaccinating teenagers

Vitamin D levels under scrutiny amid Covid surge in Europe; New UK Covid variant may be 30% more deadly, says Johnson; Bulgaria to ease some coronavirus restrictions from 4 February

Calls of UK doctors to cut the gap between the first and second doses of the coronavirus vaccine are being resisted by officials at Public Health England.

The British Medical Association (BMA) has warned that delaying the second dose of the Pfizer/BioNTech jab to 12 weeks after the first is not justified by the science.

Continue reading...

Summer holidays cancelled? UK faces big decision on border

Stricter controls appear likely, with government’s approach in stark contrast to that during first Covid wave

Slumped on the sofa after another day of home schooling, many families will have longingly eyed adverts for getaways: sun, sandy beaches and glittering pools, a much-needed reward after a year in the shadow of the coronavirus pandemic.

But ministers are becoming increasingly concerned they may have to ask the British public to sacrifice their hopes of a break abroad this summer. On Thursday, Priti Patel became the latest cabinet minister to say it was too soon to book an overseas break; Matt Hancock has already announced he is going to Cornwall.

Continue reading...

Reasons why Covid variant could kill more people are uncertain

Whatever the answer, everyone has to try even harder not to catch it in the first place

Those who may have been comforted in recent weeks by the evolutionary theory of virus mutation – that the more transmissible they become, the less lethal they are – may now be pondering the news that the variant that originated in Kent not only spreads more easily but may kill more people too.

Britain’s chief scientific adviser, Sir Patrick Vallance, at the Downing Street press briefing, said it could be that in people over 60 with Covid, 13 or 14 might die in every 1000, instead of 10 as has been the case. The reasons still seem to be uncertain.

Continue reading...

Covid vaccines: what are the implications of new variants of virus?

UK, South Africa and Brazil variants indicate changes may be needed

In common with others, the virus that causes Covid-19 mutates as it spreads. Most mutations have little or no effect, but some can change the behaviour of the virus. Mutations in a variant found in the UK in September has helped the virus spread more easily and potentially more dangerously. Further changes in variants that emerged in South Africa and Brazil may help the virus resist antibodies induced by vaccines and Covid infections from the first wave.

Why would the vaccines be updated?
If scientists spot new variants of coronavirus that are resistant to current vaccines then the vaccines will need to be redesigned to make them effective again. The more people who have immunity, either through vaccination or past infection, the more evolutionary pressure there is on the virus to evolve around that immunity. And when there’s lot of virus around, as there is now, there are more opportunities for resistant variants to emerge.

Continue reading...

Data on Covid infections in England suggests cautious approach best

Some survey results show that the overall picture might not be as rosy as implied by others

A quick glance at the government’s coronavirus dashboard might be fuel for optimism. But new data suggests the picture may not be so rosy.

According to the dashboard, the number of people testing positive for Covid is falling: 37,892 positive tests were reported on Thursday, compared with 62,322 on 6 January. Cases by specimen date show similar trends.

Continue reading...

World’s poor need action, not Covid ‘vaccine nationalism’, say experts

Nations outbidding each other creates an ‘immoral race towards the abyss’

Pharmaceutical companies should do more to transfer vaccine technology to prevent the poorest countries falling behind in the distribution of Covid-19 vaccines, according to an expert.

The warning came from Dag-Inge Ulstein, the co-chair of the global council trying to speed up access to Covid vaccines for the world’s poor, known as the Act (Access to Covid-19 Tools) Accelerator. Ulstein, Norway’s international development minister, oversees the drive to ensure vaccines reach the poor – the Covax programme.

Continue reading...

I’m in a UK Covid vaccine trial – should I also accept a ‘real’ jab?

My turn for an AstraZeneca dose has come up, so I need to decide whether to drop out of Novavax tests

I had two excellent pieces of news this week. They left me feeling utterly wretched.

First, my turn came up for the AstraZeneca vaccine against Covid. I was told I could have my first jab on Thursday.

Continue reading...

Johnson raises fears of lockdown in England continuing into summertime

No 10 wary of talking about easing restrictions as infection rate remains high

Boris Johnson raised fears that tough Covid restrictions could continue well into the spring and beyond on Thursday as ministers refused to be drawn on plans for any potential easing of lockdown.

While the vast majority of Tory MPs have toed the line since the new variant of the virus sent cases soaring, Downing Street’s reticence is already causing anxiety among a few backbenchers, who are urging an easing of the restrictions if vaccination rates stay on target.

Continue reading...

EU could ban travellers from Britain to contain Covid variants

Movement restrictions at EU internal borders will also dominate debate between 27 chiefs

The European Union could ban travellers from Britain and restrict movement at the bloc’s own internal borders under proposals to be debated by leaders at a videoconference summit.

The need to clamp down on the spread of the new variants of coronavirus will dominate discussions between the 27 heads of state and government on Thursday evening.

Continue reading...

Wear medical-grade masks if you can’t socially distance, Britons told

As new Covid variants emerge, scientists advise use of FFP masks that filter inflow and outflow of air

Scientists have urged Britons to wear medical-grade masks when they cannot physically distance, amid growing concerns of faster-spreading Covid-19 variants – but said that any face covering is better than none at all.

This week French health officials advised people to wear surgical masks rather than homemade fabric ones as these afford greater protection against highly contagious new variants.

Continue reading...

Indian hesitancy sets back world’s biggest Covid vaccination drive

Low uptake fuelled by fears over safety of vaccine and spread of misinformation

India’s Covid-19 vaccine drive has been hampered by turnout as low as 22% in some states, as fears over the safety of the vaccine and the spread of misinformation has fuelled widespread hesitancy.

On Saturday, India launched the world’s largest vaccination programme as it began the massive task of vaccinating its 1.3 billion citizens against coronavirus.

Continue reading...

Talking can spread Covid as much as coughing, says research

Tiny aerosols of the virus emitted when speaking linger in air for longer than larger droplets from a cough

Speaking to a friend when infected with the coronavirus could be as dangerous as coughing near them thanks to lingering particles, research has suggested.

Covid can be spread through a number of routes, including virus-containing droplets emitted when an infected person breaths, speaks or coughs – a factor experts said could help to explain why Covid seems to spread more easily in indoor settings.

Continue reading...

Single Covid vaccine dose in Israel ‘less effective than we thought’

Surge in infections dampens optimism over country’s advanced immunisation programme

Israel’s coronavirus tsar has warned that a single dose of the Pfizer/BioNTech vaccine may be providing less protection than originally hoped, as the country reported a record 10,000 new Covid infections on Monday.

In remarks reported by Army Radio, Nachman Ash said a single dose appeared “less effective than we had thought”, and also lower than Pfizer had suggested.

Continue reading...

Sri Lankan holy man’s ‘miracle’ potion for Covid turns sour

Minister who publicly drank syrup touted as coronavirus cure tests positive

A self-styled Sri Lankan holy man’s supposed miracle potion to prevent Covid-19 has turned sour after a minister who publicly drank it was taken to hospital with the virus.

Thousands defied public gathering restrictions to swamp a village in central Sri Lanka last month to get the syrup made by Dhammika Bandara.

Continue reading...

Covid-19: how do you tweak a vaccine?

The emergence of more infectious variants of Sars-CoV-2 has raised questions about just how long our vaccines will remain effective for. Although there is little evidence that the current vaccines won’t work against the new variants, as the virus continues to mutate scientists are preparing themselves for having to make changes to the vaccines in response. Speaking to Dr Katrina Pollock, science correspondent Linda Geddes asks how we can tweak the vaccines against new variants, and how likely it is we’ll end up in a game of cat and mouse with the virus

Continue reading...